SCHEMBL19592035

SCHEMBL19592035

O=C(N[C@H]1C[C@@H]1c1ccccc1)[C@@H]1CC2C[C@H]2N1

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TLR2 O60603 13/20 0.49
TLR1 Q15399 12/20 0.49
P2RX7 Q99572 1/20 0.46
CNR1 P21554 1/20 0.45
EPHX2 P34913 1/20 0.44
KDM1A O60341 1/20 0.43
SSTR4 P31391 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL16714405 0.93 SMN1; SMN2 (0.47) SMN1; SMN2NPSR1TLR2TLR1P2RX7
Trifluoroacetic Acid SCHEMBL16714355 0.79 CFD (0.38) SMN1; SMN2NPSR1TLR2TLR1P2RX7
SCHEMBL6153775 0.77 SMN1; SMN2 (0.73) SMN1; SMN2NPSR1TLR2TLR1CNR1
SCHEMBL3457343 0.77 SMN1; SMN2 (0.73) SMN1; SMN2NPSR1TLR2TLR1CNR1
SCHEMBL6154005 0.77 SMN1; SMN2 (0.73) SMN1; SMN2NPSR1TLR2TLR1CNR1
SCHEMBL7980208 0.77 SMN1; SMN2 (0.73) SMN1; SMN2NPSR1TLR2TLR1CNR1
Rolicyprine SCHEMBL30616025 0.74 SMN1; SMN2 (0.52) SMN1; SMN2NPSR1TLR2TLR1P2RX7
Rolicyprine SCHEMBL49385 0.74 SMN1; SMN2 (0.52) SMN1; SMN2NPSR1TLR2TLR1P2RX7
SCHEMBL25022000 0.74 TLR2 (0.60) SMN1; SMN2NPSR1TLR2TLR1KDM1A
SCHEMBL22622428 0.74 TLR2 (0.60) SMN1; SMN2NPSR1TLR2TLR1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9815819-B2 Complement pathway modulators and uses thereof NOVARTIS AG (CH) 2017-11-14 US disclosed